As part of the DEA’s National Prescription Drug Take Back Day this Saturday, multiple law enforcement agencies in the ...

We are seeking highly motivated Postdoctoral Fellows, PhD students, undergraduate students, and Research Assistants. If you are interested, please email your CV to explore these opportunities further.

Endevica Bio, a privately held company developing first-in-class peptide drug candidates, announced today the dose administration for the first patient in a Phase 2 trial for its experimental drug ...

In Ghana, where traditional medicine complements modern healthcare, an increasing number of women are exploring alternative treatments, including cannabis, for breast cancer symptom management .

She continued, "With my mother, she was one of the very few people to be diagnosed with lung cancer at stage zero, and no chemotherapy, nothing. It was cut out of her and she is, touchwood ...

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist ...

In the OptiTROP-Breast01 phase 3 trial, patients with metastatic triple-negative breast cancer who received the TROP2-targeted antibody–drug conjugate sacituzumab tirumotecan experienced longer ...

Our master's degree in pharmacology is designed to provide an understanding of basic pharmacology, toxicology, drug discovery and translational science, along with an individualized program of ...

Chemotherapy disrupts brain connectivity in breast cancer patients The decision-making part of the brain undergoes alterations The disruptions worsen as chemotherapy continues A new study in the ...

Summary: New research reveals that chemotherapy can lead to rapid and widespread changes in brain connectivity in breast cancer patients. Using functional MRI scans, scientists observed disruptions in ...

Most people with cancer pass away from the complications of their cancer rather than cancer treatments, such as chemotherapy. It’s extremely difficult to determine whether there’s a ...

Triple-negative breast cancer (TNBC) is difficult to treat due to its aggressive nature. It often responds initially to chemotherapy but is the most common breast cancer to recur. When it recurs, ...